Contact this trialFirst, we need to learn more about you.
Retinoic Acid Receptor Agonist
Palovarotene for Liver Disease
Recruiting1 awardPhase 1
Phoenix, Arizona
"This trial aims to study how the liver's condition affects the processing of a single dose of a medication called palovarotene. Participants with normal liver function, moderate liver impairment, and severe liver
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service